Abstract

Sonoporation, or the use of ultrasound in the presence of cavitation nuclei to induce plasma membrane perforation, is well considered as an emerging physical approach to facilitate the delivery of drugs and genes to living cells. Nevertheless, this emerging drug delivery paradigm has not yet reached widespread clinical use, because the efficiency of sonoporation is often deemed to be mediocre due to the lack of detailed understanding of the pertinent scientific mechanisms. Here, we summarize the current observational evidence available on the notion of sonoporation, and we discuss the prevailing understanding of the physical and biological processes related to sonoporation. To facilitate systematic understanding, we also present how the extent of sonoporation is dependent on a multitude of factors related to acoustic excitation parameters (ultrasound frequency, pressure, cavitation dose, exposure time), microbubble parameters (size, concentration, bubble-to-cell distance, shell composition), and cellular properties (cell type, cell cycle, biochemical contents). By adopting a science-backed approach to the realization of sonoporation, ultrasound-mediated drug delivery can be more controllably achieved to viably enhance drug uptake into living cells with high sonoporation efficiency. This drug delivery approach, when coupled with concurrent advances in ultrasound imaging, has potential to become an effective therapeutic paradigm.

Highlights

  • In the past several decades, the scientific community has witnessed great progress in realizing “smart drug delivery” as an advanced approach to deliver gene or drugs into specific locations of patients’ body with controlled dosage release, enhanced delivery efficiency, improved biocompatibility and easy accessibility [1,2,3,4,5,6,7,8,9,10,11,12]

  • Karshafian et al investigated the sonoporation outcomes of KHT-C cells in suspensions with the presence of definity microbubbles ranging in size between 1 and 8 μm, and the results showed that higher cell permeability and lower cell viability would be induced with 500 kHz ultrasound sonication than 2 MHz and 5 MHz exposures [136]

  • Dedicated efforts have been made to unravel the essential science in sonoporation, most contemporary studies are generally centered upon either upstream physics or downstream bioeffects

Read more

Summary

Introduction

In the past several decades, the scientific community has witnessed great progress in realizing “smart drug delivery” as an advanced approach to deliver gene or drugs into specific locations of patients’ body with controlled dosage release, enhanced delivery efficiency, improved biocompatibility and easy accessibility [1,2,3,4,5,6,7,8,9,10,11,12] On this topic, ultrasoundactivated mechanical force has been regarded as one of the most promising strategies to realize spatiotemporallycontrollable drug delivery to selected regions [2, 3, 6, 13,14,15,16,17,18]. Such rationalization effort will critically bolster the overall potential of ultrasound in becoming an effective theranostic modality that synergizes its imaging and therapeutic applicability

Observational Evidence on Sonoporation
Physical and Biological Processes Related to Sonoporation
Factors Affecting Sonoporation Dynamics and Bioeffects
D Cell diameter d e distance of the bubble from the cell
Findings
Perspectives, Future Directions, and Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call